Protecting Vulnerable Patients from Infection with the EpiShuttle
In the past years FAI has been using EpiShuttle as its preferred patient isolation unit for highly infectious and vulnerable patients
In the past years FAI has been using EpiShuttle as its preferred patient isolation unit for highly infectious and vulnerable patients
With 30 EpiShuttles covering the country, the United Kingdom (UK) is at the forefront of patient isolation transport with its EpiShuttle implementation.
As the curtains close on the remarkable journey of 2023, EpiGuard takes a moment to reflect on a year filled with achievements, collaborations, and global impact.
From saving resources and being super-efficient to getting ready for future challenges, EpiShuttle is not just changing how we transport people, it’s also making healthcare more eco-friendly.
We announce our latest global expansion – the Asian market. As we take this leap, we are particularly thrilled to introduce our newest distributors, both led by ambitious female leaders!
EpiGuard is proud to announce that the EpiShuttle has secured a vital place in the 100% EU-funded Strategic CBRN Reserve!
Two Scandinavian countries, Sweden and Norway, have perfected the process of patient transport. They have been conducting training exercises using the EpiShuttle, which ensures the safety of both patients and healthcare professionals.
EpiGuard’s single patient isolation transport unit is the only unit of its kind at the Westmead biocontainment centre!
When it comes to transporting infectious patients, quality matters! EpiShuttle, the industry standard in single patient isolation units (PIUs), offers unmatched reliability. Check specifications for choosing PIU for your organisation here.
EpiGuard is happy to announce our latest partnership with JS T&C, a prominent player in Korea’s healthcare landscape!